Four new retailers from US, two from Germany may have shown interest in setting up shop in India.
Some leading Indian companies are likely to see their earnings declining if the Indian currency depreciates further, analysts and finance heads say.
Issue in two months for Australian projects; group to invest another $15 billion in infrastructure projects by 2020.
The two companies have approached banks to raise up to Rs 8,000 crore as debt to fund their expansion plans.
Some investment bankers expect the Indian currency to touch 60-65 by the end of the year
An official said next week, the Department of Industrial Policy and Promotion was likely to issue clarifications sought by the sector on the government's multi-brand retail policy.
SBI says recovery process on as no court stay yet.
DEA objects to the company's 29 Indian stores having sub-brands as a rule violation; DIPP doesn't agree.
Patience has kept IKEA, the euro 27-billion Swedish retailer, going despite entry hurdles. So says Juvencio Maeztu, its chief executive officer for India.
Patience has kept IKEA, the euro 27-billion Swedish retailer, going despite entry hurdles. So says Juvencio Maeztu, its chief executive officer for India.
Many top firms have had to write down their investments, as the value of those have collapsed due to sluggish biz conditions.
CEOs point fingers at rural job guarantee and related govt welfare schemes; say mechanisation an increasingly viable option.
Lack of time was cited as the main reason for Bharti Chairman Sunil Mittal's exit from the Unilever board.
FDI policy for multi-brand retail has been a sore point for the retail chain.
Retailers can buy existing facilities if they spend $50 mn to create additional infra.
Merchant bankers appointed to explore options on merger or stake sale in Tata Teleservices.
However, foreign investors have completely shunned the infrastructure sector.
Bharti was talking to Standard Chartered Bank and Citibank, among others, to manage the issue.
Officina Farmaceutica Italiana mainly deals in large-scale contract manufacturing for cosmetics and drug majors
These companies gave annualised returns of 11% on an average in the last five years, while shareholders of family-owned companies saw 5% annualised erosion